Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;17(1):3-13.
doi: 10.1038/ejhg.2008.165. Epub 2008 Sep 10.

Prader-Willi syndrome

Suzanne B Cassidy  1 , Daniel J Driscoll
Affiliations

Prader-Willi syndrome

Suzanne B Cassidy et al. Eur J Hum Genet. 2009 Jan.

Abstract

Prader-Willi syndrome (PWS) is a highly variable genetic disorder affecting multiple body systems whose most consistent major manifestations include hypotonia with poor suck and poor weight gain in infancy; mild mental retardation, hypogonadism, growth hormone insufficiency causing short stature for the family, early childhood-onset hyperphagia and obesity, characteristic appearance, and behavioral and sometimes psychiatric disturbance. Many more minor characteristics can be helpful in diagnosis and important in management. PWS is an example of a genetic condition involving genomic imprinting. It can occur by three main mechanisms, which lead to absence of expression of paternally inherited genes in the 15q11.2-q13 region: paternal microdeletion, maternal uniparental disomy, and imprinting defect.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hypotonia of infancy in a one-month-old male with PWS. Note frogleg position and need for a feeding tube. Also note dolichocephaly and hypoplastic, empty scrotum.
Figure 2
Figure 2
Central obesity of PWS in (a) a 2 ½ year old girl and (b) a 21-year-old male. Note also typical facial appearance, active skin picking lesions and gastrostomy feeding tube scar in the girl, pseudogynecomastia and genus valgus in the male.
Figure 3
Figure 3
Classical facial phenotype of PWS in adolescence and adulthood. (a) A 15-year-old male. (b) A 41-year-old female. Note narrow bifrontal diameter, almond-shaped and slightly upslanting eyes, narrow nasal bridge, and thin upper lip.
Figure 4
Figure 4
Molecular classes of PWS and their frequencies. Deletion 15q11.2–q13, maternal uniparental disomy (UPD), imprinting defect (ID) and single gene mutation. The parent of origin of each chromosome is indicated with M (maternal) or P (paternal). Note that there is biparental contribution of the two chromosomes 15 in the case of ID, but the paternal (P) contribution in 15q11.2–q13 has maternal (M) epigenetic markings (eg, DNA methylation) and behaves accordingly.
Figure 5
Figure 5
Summary of the genetic and expression map of chromosomal region 15q11.2–q13. The position of genes and genetic markers (circles) are shown. In the PWS region (shown in blue), there are six paternal-only (PWS region) expressed unique copy genes (MKRN3, MAGEL2, NECDIN, C15ORF2 and SNURF- SNRPN and a family of five paternal-only expressed snoRNA genes). Only UBE3A and ATP10A (shown in red), related to Angelman syndrome (AS), have maternal-only expression in mouse and humans, and this imprinted expression is limited to certain tissue-specific regions (ie, brain). The bipartite imprinting center (IC) lies proximal to SNURF-SNRPN and within the 3 Mb PWS/AS imprinted region. The cluster of GABA receptor genes (GABRB3, GABRA5 and GABRG3), OCA2 (type II albinism) and HERC2 are not imprinted and have biparental expression (shown in black). The jagged vertical lines denote the common 5–7 Mb AS and PWS deletion breakpoints, which lie within the segmental duplications associated with BP1, BP2 and BP3. There are two common proximal breakpoints and one distal common breakpoint. In between BP1 and BP2 lie four additional, non-imprinted genes GCP5 (TUBGCP5), CYFIP1, NIPA2 and NIPA1. Type 1 deletions extend from BP1 to BP3 and type 2 deletions extend from BP2 to BP3. Note that there are more copies of the HBII-85 and HBII-52 genes than are shown.
Figure 6
Figure 6
Normalization of the body and facial phenotype of PWS following treatment with growth hormone from infancy. (a) A 7-year-old unaffected sibling on the left and his 8-year-old brother with PWS on the right. Note lighter pigmentation in affected brother who has a typical deletion, and scar from the gastrostomy tube used in infancy. The unaffected brother has 24% body fat and the brother with PWS has 20% body fat. (b) A 2-year-old boy. (c) A 4-year-old unrelated boy.
See this image and copyright information in PMC

Comment in

  • Prader-Willi and Angelman syndromes: genetic counseling.
    Camprubí C, Coll MD, Gabau E, Guitart M. Camprubí C, et al. Eur J Hum Genet. 2010 Feb;18(2):154-5; author reply 155-6. doi: 10.1038/ejhg.2009.170. Epub 2009 Oct 7. Eur J Hum Genet. 2010. PMID: 19809481 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Miller SP, Riley P, Shevell MI. The neonatal presentation of Prader-Willi syndrome revisited. J Pediatr. 1999;134:226–228. - PubMed
    1. Gunay-Aygun M, Schwartz S, O'Riordan MA, Cassidy SB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 2001;108:E92. - PubMed
    1. Crinó A, Schiaffini R, Ciampalini P, et al. Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr. 2003;162:327–333. - PubMed
    1. Dykens EM, Hodapp RM, Walsh K, Nash L. Profiles, correlates and trajectories of intelligence in individuals with Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry. 1992;31:1125–1130. - PubMed
    1. Curfs LM, Fryns JP. Prader-Willi syndrome: a review with special attention to the cognitive and behavioral profile. Birth Defects Orig Artic Ser. 1992;28:99–104. - PubMed

Further Reading

    1. Cassidy SB, Schwartz S.Prader-Willi Syndrome GeneReviewsCopyright, Seattle: University of Washington; updated March 2008. http://www.genetests.org .
    1. Goldstone AP. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab. 2004;15:12–20. - PubMed
    1. McCandless SE, Cassidy SB.15q11-13 and the Prader-Willi syndromein: Epstein CJ, Erickson RP, Wynshaw-Boris A (eds): Molecular Basis of Inborn Errors of Development Oxford University Press; 2008. 3rd edn, ch. 105.
    1. Prader-Willi Syndrome Association (USA) website: www.pwsausa.org .

Publication types

MeSH terms

Substances